Design Therapeutics, Inc. (DSGN) ownership: Top institutional holder: SR One Capital Management, LP ($69.44M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SR One Capital Management, LP | 6526476.00 | $69.44M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 2972973.00 | $31.63M | 2026-03-31 |
| Point72 Asset Management, L.P. | 2722754.00 | $28.97M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 2585978.00 | $27.51M | 2026-03-31 |
| BlackRock, Inc. | 2133764.00 | $22.70M | 2026-03-31 |
| Logos Global Management LP | 1950000.00 | $20.75M | 2026-03-31 |
| Driehaus Capital Management LLC | 1744987.00 | $18.57M | 2026-03-31 |
| Vivo Capital, LLC | 1612903.00 | $17.16M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-03-31 | |
| Sell | null | 2026-03-31 |
Back to DSGN overview · DSGN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.